Jinhe Biotechnology Co Ltd (002688) — Strategic Asset Allocation Index
Jinhe Biotechnology Co Ltd (002688) has a Strategic Asset Allocation Index of 70.5% as of September 2023. Strategic assets (PP&E of CN¥1.79 Billion plus long-term investments of CN¥-) total CN¥1.79 Billion, measured against net assets of CN¥2.54 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Jinhe Biotechnology Co Ltd Strategic Asset Allocation Index (2009–2022)
This chart shows how Jinhe Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of September 2023, the index stands at 70.5%, representing strategic assets of CN¥1.79 Billion against net assets of CN¥2.54 Billion CNY. Explore 002688 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Jinhe Biotechnology Co Ltd (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jinhe Biotechnology Co Ltd from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Jinhe Biotechnology Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 66.9% | CN¥1.62 Billion | CN¥1.62 Billion | CN¥- | CN¥2.43 Billion | ▲ +22.1 pp |
| 2021 | 44.8% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥2.70 Billion | ▼ -14.9 pp |
| 2020 | 59.7% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥1.75 Billion | ▲ +5.9 pp |
| 2019 | 53.9% | CN¥973.07 Million | CN¥973.07 Million | CN¥- | CN¥1.81 Billion | ▲ +4.6 pp |
| 2018 | 49.3% | CN¥876.78 Million | CN¥874.64 Million | CN¥2.14 Million | CN¥1.78 Billion | ▲ +2.4 pp |
| 2017 | 46.9% | CN¥768.29 Million | CN¥766.90 Million | CN¥1.38 Million | CN¥1.64 Billion | ▲ +3.8 pp |
| 2016 | 43.2% | CN¥683.57 Million | CN¥682.79 Million | CN¥776.03K | CN¥1.58 Billion | ▼ -31.8 pp |
| 2015 | 75.0% | CN¥790.68 Million | CN¥565.44 Million | CN¥225.23 Million | CN¥1.05 Billion | ▲ +23.8 pp |
| 2014 | 51.2% | CN¥489.17 Million | CN¥489.17 Million | CN¥- | CN¥956.13 Million | ▲ +2.5 pp |
| 2013 | 48.6% | CN¥437.71 Million | CN¥437.71 Million | CN¥- | CN¥900.07 Million | ▲ +10.4 pp |
| 2012 | 38.2% | CN¥330.00 Million | CN¥330.00 Million | CN¥- | CN¥863.55 Million | ▼ -64.1 pp |
| 2011 | 102.3% | CN¥342.03 Million | CN¥342.03 Million | CN¥- | CN¥334.40 Million | ▼ -23.1 pp |
| 2010 | 125.4% | CN¥319.60 Million | CN¥319.60 Million | CN¥- | CN¥254.83 Million | ▼ -28.0 pp |
| 2009 | 153.4% | CN¥300.65 Million | CN¥300.65 Million | CN¥- | CN¥196.03 Million | — |